The deal is a bet on the growing market for psychiatric and neurological drugs.
Author: Lauren Hirsch
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion